Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › Wisconsin
Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials in Wisconsin
3 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are looking for participants at sites in Wisconsin.
Cities in Wisconsin
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Site Number - 1613, Milwaukee
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07032662A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, Milwaukee
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT06680037A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- BCN Research, LLC, Greenfield
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jan 20, 2026 · NCT06747351From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.